Summary: NIH reported that a clinical trial found a common antiviral drug did not improve Long COVID symptoms when given for up to 25 days, underscoring the difficulty of finding effective treatments.
Introduction
Long COVID can leave people dealing with fatigue, brain fog, breathlessness, and other symptoms long after an initial infection. For patients who have had to rearrange work and family life around symptoms, each new study brings a difficult question: could this be the treatment that helps? A recent clinical trial offers a sobering answer about one possible approach.
What Happened
In its September 29 research update, NIH reported that a clinical trial testing a commonly used antiviral drug for up to 25 days did not improve Long COVID symptoms. The finding does not mean every antiviral or every treatment strategy will fail; it speaks to the particular medicine and study that were tested.
Why It Matters
Negative results are still useful. They help clinicians avoid assuming that a medicine effective for acute infection will necessarily help symptoms that persist for months. They also help researchers refine theories about what drives Long COVID and which patient groups may respond to particular interventions.
Challenges and Next Steps
Long COVID is not identical for every patient, and researchers continue to investigate its different biological pathways. People experiencing persistent symptoms should seek individualized medical advice rather than start or extend prescription medication on their own. More trials are needed to evaluate other possible treatments and supportive approaches.
Conclusion
The result may be disappointing for people hoping for a quick answer, but it adds evidence to a field that needs it. Progress will require careful studies, honest reporting of negative findings, and continued attention to patients’ daily needs.
Works Cited
National Institutes of Health, NIH Research Matters. “Antiviral Drug Did Not Improve Long COVID Symptoms.” 29 Sept. 2026. https://beta.nih.gov/nih-research-matters